A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy

Title
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
Authors
Keywords
triple negative breast cancer, cancer immunotherapy, nucleolin, human RNase, microRNA.
Journal
Oncotarget
Volume 7, Issue 52, Pages -
Publisher
Impact Journals, LLC
Online
2016-11-24
DOI
10.18632/oncotarget.13522

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started